Fig. 3From: Assessment of the nevirapine safety signal using data from the national antiretroviral dispensing database: a retrospective studyA major increase in TDF as a part of the nucleoside backbone in first line antiretroviral therapy is observed in the last quarter of 2010. Although a reduction is observed in the consequent months, the use of TDF remained high compared to what it was in the earlier quartersBack to article page